EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Genetic Determinants of Inter-Individual Variability in Statin Therapy

Agnieszka Olejnik, Edward Zheng, Maria Możdżan, Laura Biskup, Beata Huszcza, Konrad Gronek, Julia Kaczmarek, Jakub Grandos, Dominik Gajewski, Zuzanna Głowacka, Kinga Kościołek

Quality in Sport · 19.03.2026 · 53 · 69507

DOI: 10.12775/qs.2026.53.69507 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Quality in Sport, online erschienen am 19.03.2026. Verfasst von Agnieszka Olejnik und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Statins, or HMG-CoA reductase inhibitors, represent one of the most extensively researched and frequently prescribed pharmacological agents, primarily utilized to reduce cardiovascular risk through the modulation of serum cholesterol levels. Although their efficacy in reducing global mortality and cardiovascular events is well-established, genetic variability persists among different populations which may predispose patients to dose-related adverse effects and reduced efficancy of statin therapy. This heterogeneity has driven a shift in the scientific landscape toward exploring common genetic polymorphisms within the genes encoding genes involved in pharmacodynamic pathways. This review aims to provide a comprehensive analysis of clinically significant polymorphisms within the pharmacodynamic pathways of statins.

Methods

A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria.

Conclusions

Despite rapid progress in the field of pharmacogenomics, the role of genetic polymorphisms among genes involved in pharmacodynamic pathways of statin therapy still requires more research in order to establish robust evidence of their role in the overall lipid-lowering efficacy of statins.

Zitieren

APA

Olejnik, A., Zheng, E., Możdżan, M., Biskup, L., Huszcza, B., Gronek, K., Kaczmarek, J., Grandos, J., Gajewski, D., Głowacka, Z., & Kościołek, K. (2026). Genetic Determinants of Inter-Individual Variability in Statin Therapy. Quality in Sport, 53, 69507. https://doi.org/10.12775/qs.2026.53.69507

Vancouver

Olejnik A, Zheng E, Możdżan M, Biskup L, Huszcza B, Gronek K, et al. Genetic Determinants of Inter-Individual Variability in Statin Therapy. Quality in Sport. 2026;53:69507. doi:10.12775/qs.2026.53.69507

BibTeX
@article{Olejnik2026,
  author = {Olejnik, Agnieszka and Zheng, Edward and Możdżan, Maria and Biskup, Laura and Huszcza, Beata and Gronek, Konrad and Kaczmarek, Julia and Grandos, Jakub and Gajewski, Dominik and Głowacka, Zuzanna and Kościołek, Kinga},
  title = {Genetic Determinants of Inter-Individual Variability in Statin Therapy},
  journal = {Quality in Sport},
  year = {2026},
  volume = {53},
  pages = {69507},
  doi = {10.12775/qs.2026.53.69507}
}
Kostenlos starten →